Respiratory Flashcards

1
Q

Define asthma

A

Chronic inflammatory airway disease characterised by intermittent reversible airway obstruction, bronchial hyper-responsiveness and inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the aetiology of asthma?

A

Multi-gene association interacting with environmental exposure

  1. Initial trigger leads to the release of inflammatory mediators
  2. Activation and migration of other inflammatory cells.
  3. Th2 lymphocytic response - release of interleukins, chemokines etc.
  4. Inflammatory cells move to the airway, causing changes in the epithelium, airway tone, hyper-secretion of mucus, mucociliary function alteration and increased smooth muscle responsiveness.
Acute:
SM contraction leading to bronchoconstriction
Mucus hypersecretion
Oedema
Airway obstruction

Chronic:
Proliferation of SM cells and fibroblasts causing airway remodelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the risk factors of asthma?

A
Family history
Atopic history - eczema, dermatitis, allergic rhinitis
Obesity
GORD
Nasal polyposis
Exposure to allergens/precipitants:
Cats
Dogs
Cockroaches
Dust mites
Fungal spores
Tobacco smoke
Fumes from chemicals eg bleach
Pollen from trees, weeds, and grass.
Viral infections - rhinovirus, influenza 
Bacterial infections - Mycoplasma pneumoniae, chlamydia pneumoniae
Cold
Exercise
Extreme emotion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Summarise the epidemiology of asthma

A

Affects 10% of adults and 5% of children
Prevalence is increasing
Highest hospitalisation rates and asthma deaths were amongst black patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the presenting symptoms of asthma?

A

Cough
Wheeze
SOB/dyspnoea precipitated by allergen exposure
Chest pain/tightness
Nocturnal symptoms
Worse at night
Variation in symptoms (episodic history) - sometimes fine and sometimes symptomatic

Previous hospitalisation for asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the signs on physical examination of asthma?

A
Nasal polyps/congestion
Polyphonic high-pitched expiratory wheeze
Tachypnoea
Prolonged expiratory phase
Hyperinflated chest
Chest may be silent in severe asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the appropriate investigations for asthma?

A

Forced Expiratory Volume in 1 second/Forced Vital Capacity - <80% of predicted

FEV1 <80% of expected

PEFR - variation >20% over 3 days a week over several weeks. >20% increase following bronchodilator therapy

ACUTE:
Peak flow
Pulse oximetry
ABG
CXR - to exclude other diagnoses (e.g. pneumonia, pneumothorax). Normal or hyperinflated. May show signs of infection.
FBC - raised WCC if infective exacerbation
CRP
U&amp;Es
Blood and sputum cultures

CHRONIC:
Peak flow monitoring - often shows diurnal variation with a dip in the morning
Pulmonary function test
Bloods - Eosinophilia, IgE level, Aspergillus antibody titres
Skin prick tests - identify allergens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the management of an acute exacerbation of asthma?

A

ABCDE and necessary resuscitation
Monitor O2 sats, ABG, PEFR and U&Es (K+ lowered by bronchodilators)
High-flow oxygen (get to 94-98%)
Salbutamol nebulizer (5 mg initially continuously, then 2-4 hourly)
Nebulised Ipratropium bromide (0.5 mg QDS)

Steroid therapy: 100-200 mg IV hydrocortisone. THEN, 40 mg oral prednisolone for 5-7 days
If no improvement - IV magnesium sulphate
Consider IV aminophylline infusion
Consider IV salbutamol

May need ITU and ventilation if fatiguing.
- Normal PCO2 is a BAD SIGN as they should be hyperventilating and blowing off their CO2 (PCO2 should be low)

Treat underlying cause (e.g. antibiotics if it is an infective exacerbation)

DISCHARGE when:
PEF > 75% predicted
Diurnal variation < 25%
Inhaler technique checked
Stable on discharge medication for 24 hours
Patient owns a PEF meter
Patient has steroid and bronchodilator therapy
Arrange follow-up
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the management of chronic asthma?

A

Start on the step that matches the severity of the patient’s asthma

  1. Inhaled short-acting beta-2 agonist used as needed eg SALBUTAMOL
    If needed > 1/day then move onto step 2
  2. SABA + regular inhaled low-dose steroids (400mcg/day)
  3. SABA + low-dose steroids + inhaled long-acting beta-2 agonist
    If inadequate control with LABA, increase steroid dose (800 mcg/day)
    If no response to LABA, stop LABA and increase steroid dose (800 mcg/day)
  4. Increase inhaled steroid dose (2000 mcg/day)
    Add 4th drug (e.g. leukotriene antagonist, slow-release theophylline or beta-2 agonist tablet)
  5. Add regular oral steroids
    Maintain high-dose oral steroids
    Refer to specialist care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the possible complications of asthma?

A
Exacerbations
Airway remodelling
Oral candidiasis secondary to incorrect use of inhaled corticosteroids
Growth retardation
Chest wall deformity – Harrison’s sulcus
Recurrent infections
Pneumothorax
Respiratory failure
Death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the prognosis of asthma?

A

Patients with well-controlled asthma have the same life expectancy as patients without
Many children improve as they get older
Adult-onset asthma is usually chronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define COPD

A

A chronic progressive lung condition that is characterised by irreversible airflow obstruction which encompasses emphysema and chronic bronchitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is emphysema and describe its aetiology?

A

Pathological diagnosis of permanent destructive enlargement of air spaces distal to the terminal bronchioles

Destruction and enlargement of alveoli due to elastin breakdown, causing loss of the elastic traction that keeps small airways open in expiration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is chronic bronchitis and describe its aetiology?

A

Chronic cough and sputum production on most days for at least 3 months per year over 2 consecutive years

Narrowing of the airways due to bronchiole inflammation and bronchi with mucosal oedema, mucous hypersecretion (increased goblet cell size and number) and squamous metaplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the causes/risk factors of COPD?

A
CIGARETTE SMOKING
Advanced age
White ancestry
Air pollution
Occupational exposure (dust, traffic fumes, sulphur dioxide)
Male sex
Developmentally abnormal lung
Genetic disorders eg alpha-1 antitrypsin deficiency (common cause in young, non-smokers)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Summarise the epidemiology of COPD

A

More common in those over 65 years old
Slightly higher prevalence in men
Very common - prevalence up to 8%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the presenting symptoms of COPD?

A
Chronic cough and white frothy sputum production (often in morning)
Progressively worsening SOB
Fatigue
Wheeze
Reduced exercise tolerance
History of smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the signs on physical examination of COPD?

A
Barrel chest
Hyper-resonance on auscultation
Quiet breath sounds, prolonged expiration, crepitations
Wheeze
Coarse crackles
Tachypnoea
Tchycardic
Asterixis
Cyanosis 
Clubbing
Use of accessory muscles
Bounding pulse

In late stages, signs of right heart failure i.e. raised JVP, ankle oedema, RV heave

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are appropriate investigations for COPD?

A

Spirometry - FEV1/FVC <0.7
Pulse oximetry - low O2 sats (88-90%)
CXR - hyperinflation (>6 anterior ribs visible, flat hemidiaphragms)
ECG - risk factors for COPD similar to those of IHD
Alpha-1 antitrypsin

Acute presentation:
ABG - PaCO2 >50mmHg +/- PaO2 <60mmHg suggests respiratory insufficiency
FBC - increased WCC and haematocrit, raised Hb (secondary polycythaemia)
Sputum culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the management of an acute exacerbation of COPD?

A

Short acting bronchodilator
Systemic corticosteroid which is transferred to inhaled corticosteroid
Airway clearance techniques (respiratory physio to clear sputum)
Supplementary O2 - 24% via non-variable flow Venturi Mask (aim for 88-92% O2 sats)
Antibiotics if infectious exacerbation
Non-invasive positive pressure ventilation if respiratory insufficiency (BiPAP)

Prevent infective exacerbations: pneumococcal & influenza vaccination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the management of COPD?

A

Short or long-acting bronchodilator (SABA or LABA, anti-cholinergics eg ipratropium bromide via inhaler or nebs)
If LABAs used >2 exacerbations per year - use steroids (oral eg prednisolone or inhaled eg budesonide)
Patient education and prophylactic vaccination
Smoking cessation
Pulmonary rehabilitation
Long term O2 therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are possible complications of COPD?

A
Cor pulmonale - R sided heart failure secondary to long-standing COPD (chronic hypoxia - pulmonary vasoconstriction - pulmonary hypertension)
Recurrent pneumonia
Pneumothorax
Respiratory failure
Anaemia
Secondary polycythaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the prognosis of COPD?

A

Variable prognosis dependent on genetic predisposition, environmental exposure, comorbidities
High level of morbidity
Three-year survival rate 90% if <60 years old, FEV1>50% predicted
Three-year survival rate 75% if >60 years old and FEV1 40-49% predicted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Define acute respiratory distress syndrome

A

Syndrome of acute and persistent lung inflammation with increased vascular permeability due to non-cardiogenic pulmonary oedema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What are the four characteristics of Acute Respiratory Distress syndrome?

A
  1. Symptoms occur within 1 weeks of insult
  2. CXR shows diffuse bilateral opacities
  3. Pulmonary oedema cannot be explained by heart failure (no clinical evidence for increased left atrial pressure so PCWP <18mmHg)
  4. PaO2:FiO2 < 300mmHg (hypoxaemia regardless of level of positive-end expiratory pressure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Summarise the aetiology of acute respiratory distress syndrome

A

Systemic inflammation causes cytokines secretion leading to damage to alveolar or capillary endothelium.
Increases permeability of membrane, leading to fluid moving into alveoli - PULMONARY OEDEMA.
Fluid prevents normal gas exchange and surfactant is diluted leading to eventual alveolar collapse - DECREASED LUNG COMPLIANCE.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are risk factors for acute respiratory distress syndrome?

A
Sepsis - pneumonia, UTI, infected intravenous line
Acute pancreatitis
Burns injury
Trauma
Near drowning
DIC
Toxic smoke inhalation
Aspiration of gastric contents
Transfusion
Drug overdose/reaction
Transplantation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Summarise the epidemiology of acute respiratory distress syndrome

A

Annual UK incidence ~ 1 in 6000
Critical illness, cigarette smoking and alcohol use are predisposing factors.
Most common cause is sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the presenting symptoms of acute respiratory distress syndrome?

A
Severe shortness of breath
Rapidly worsening respiratory failure
Cough
Respiratory distress
Dyspnoea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the signs on physical examination of acute respiratory distress syndrome?

A
Cyanosis
Tachypnoea
Hypoxaemia
Diffuse crackles on auscultation - widespread inspiratory crepitations
Tachycardia
Signs are BILATERAL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What are the appropriate investigations for acute respiratory distress syndrome?

A

CXR - will show bilateral opacities if ARDS
ABG - low PaO2 - HYPOXAEMIA

Investigations to determine cause:
Sputum culture - positive for infectious agent if sepsis is cause
Blood culture - test for any underlying infection causing sepsis
Urine culture - test for any underlying infection eg UTI causing sepsis
Amylase and lipase - raised if acute pancreatitis is underlying cause
Bloods - FBC, U&E, LFT, ESR/CRP, clotting

Investigations to rule out cardiogenic pulmonary oedema:
Serum BNP - raised if due to heart failure
Echo - if due to heart failure would show decreased ejection fraction or abnormal relaxation of myocardium
Pulmonary artery catheterization: PCWP <18 mmHg (if higher suggests heart failure as cause of pulmonary oedema due to raised pulmonary BP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Define pulmonary embolism

A

Occlusion of the pulmonary vasculature (usually pulmonary arteries) by a venous thromboembolus usually from the deep veins of the lower limbs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Summarise the aetiology and risk factors of pulmonary embolism

A

VIRCHOW’S TRIAD

A venous thromboembolus travels through the circulation to the pulmonary vasculature where it causes an occlusion
Usually from a DVT in the lower limb.
Most PEs originate from the veins above the knee
Rarely from right atrium in patients with AF
Other embolising agents: amniotic fluid, air, fat, tumour, septic emboli (from Right Sided Endocarditis)

Risk factors:
Bed ridden >3 days
Recent surgery <12 weeks
Recent long haul flight or care journey
Sedentary lifestyle
OCP
Genetic coagulation disorders - factor V leiden, protein C deficiency
Trauma
Pregnancy
Obesity
Active cancer
Smoking 
Varicose veins
Previous or FHx of DVT or thromboembolic event
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Summarise the epidemiology of pulmonary embolism

A

Relatively common especially in hospitalised patients

Occur in 10-20% of people with confirmed proximal DVT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What are the presenting symptoms of pulmonary embolism?

A

Small PE - asymptomatic

Sudden onset, severe, PLEURITIC chest pain
Chest pain better on leaning forwards
Dyspnoea
Cough
Haemoptysis
Fatigue
Fever 
Feeling of apprehension 
Large (or proximal): 
Shock  
Syncope
Acute right heart failure 
Sudden death

Symptoms of DVT:
Unilateral, painful, erythematous swelling of leg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

What are the signs on physical examination of pulmonary embolism?

A

Small: often no clinical signs, however, the earliest signs are tachycardia and tachypnoea

Moderate: 
Tachypnoea
Tachycardia
Pleural Rub
Hypoxaemia 

Massive PE:
Shock (increased HR and RR, decreased BP)
Cyanosis
Signs of Right Heart Strain (increased JVP, Left parasternal heave, accentuated S2 heart sound)

Multiple small recurrent:
Signs of pulmonary HTN and right heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are the appropriate investigations for a pulmonary embolism?

A

Wells Score: should be calculated in patients with suspected PE

CTPA - direct visualisation of of thrombus in pulmonary artery - DIAGNOSTIC!!

Ventilation-Perfusion (V/Q) Scan - area is ventilated but NOT perfused. If negative, excludes PE
D-dimer - elevated
ECG - sinus tachycardia, right axis deviation, RBB
CXR: often normal, but done to exclude other DDx
Echo: may show right heart strain
Doppler USS Lower Limbs: to examine for venous thrombosis
ABG - respiratory alkalosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What is the management of a pulmonary embolism?

A

DVT prevention:
Compression stockings
Regular calf exercises in periods of immobility
Heparin prophylaxis i.e. pre-surgery
Early mobilisation and hydration post-surgery

Prevention of further PE:
Anticoagulation eg warfarin, heparin
Surgically place filter in IVC

If Haemodynamically stable:
Respiratory Support: Supplemental high concentration O2 (Target saturations 94-8%)
Anticoagulation with heparin or LMW heparin
Change to oral warfarin therapy (INR 2-3) for a minimum of 3 months
Analgesia

If Haemodynamically Unstable: 
Resuscitate: give O2 and IV fluid 
Thrombolysis i.e. Alteplase 
Vasoactive agents for Hypotension i.e. noradrenaline 
Anticoagulation i.e. LMWH

Thrombectomy if needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What are the possible complications of pulmonary embolism?

A
Sudden cardiac death
Cardiac arrest
Right heart failure
Pulmonary hypertension
Recurrent venous thromboembolism
Pulmonary infarction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Summarise the prognosis of pulmonary embolism

A

30% mortality in untreated (8% in those with treatment due to recurrent emboli)
Patients have an increased risk of future thromboembolic events

41
Q

Define sarcoidosis

A

A chronic granulomatous disorder of exclusion which commonly affects the lungs, skin and eyes. It is associated with the formation of non-caseating granulomas and accumulation of lymphocytes and macrophages.

42
Q

Summarise the aetiology and risk factors of sarcoidosis

A

Aetiology is unknown

Risk factors:
African American
Scandinavian origin
Age 20-40 years
Female 
Family history of sarcoidosis
Recent infection with mycobacterium tuberculosis or borrelia burgdorferi
43
Q

Summarise the epidemiology of sarcoidosis

A

Higher incidence in those of Scandinavian descent
Women are more likely to have eye and neurological involvement and have erythema nodosum
Men are more likely to be hypercalcaemic

44
Q

What are the presenting symptoms of sarcoidosis?

A
Fever
Weight loss
Fatigue
Dyspnoea
Visual changes - blurred vision
Non-productive cough
Wheezing (bronchospasm due to airway hyperactivity) 
Red, painful eye 
Arthralgia (pain in knees, ankles and wrists)
45
Q

What are the signs on physical examination of sarcoidosis?

A

Rhonchi (bronchospasm due to airway hyperactivity)
Arthralgia with NO synovial thickening on examination
Lymphadenopathy - enlarged, non-tender (cervical, submandibular nodes involved)
Photophobia (usually indicated uveitis)
Tender Erythema nodosum (on lower extremities)
Lupus pernio (hardened plaques with discolouration of nose, cheeks, lips & ears)
Conjunctival Nodules (with ocular involvement)
Facial Palsy
Arrhythmias

46
Q

What are the appropriate investigations of sarcoidosis?

A

CXR: BILATERAL HILAR LYMPHADENOPATHY and non-caseating granulomas
Hilar and/or paratracheal adenopathy with upper lobe predominant, bilateral infiltrates; pleural effusions (rare) and egg shell calcifications (very rare) may be seen

Bloods:
Calcium - elevated as macrophages produce this
ACE - elevated as T cells produce this
Serum Urea & Creatinine (may be elevated)
Liver Enzymes (elevated)

Pulmonary Function: monitoring, persistent decline in FVC indicates disease progression
ECG: to exclude or confirm cardiac involvement
CT
Bronchoalveolar Lavage - increased T cells
Biopsy - shows non-caseating granulomas

47
Q

Define tuberculosis

A

Tuberculosis is an infectious granulomatous disease caused by mycobacterium tuberculosis that mainly affects the lungs. It can remain latent in patients for a long time.

48
Q

Explain the aetiology and risk factors of tuberculosis

A

TB is caused by mycobacterium tuberculosis and is passed via inhalation of aerolised droplets containing mycobacterium
Mycobacterium Tuberculosis is an intracellular organism that survives after being phagocytosed in macrophages.

Risk factors:
Immunosuppression eg HIV
Iatrogenic immunosuppression eg corticosteroid use
Living in or visiting an endemic country
Systemic diseases - COPD, diabetes, end-stage renal disease
Age extremes
Exposure to infectious TB case
IV drug use
Apical fibrosis
Silicosis
49
Q

Summarise the epidemiology of tuberculosis

A

9th leading cause of death worldwide
Leading cause of death from a single infectious agent
More than half of all cases were in either India, Indonesia, China, the Phillipines or Pakistan
Most common in Asian patients
2 billion people are infected worldwide

50
Q

What are the presenting symptoms of tuberculosis?

A

Primary TB is often asymptomatic
Most patients have mild flu-like symptoms

Fever
Weight loss
Night sweats
Cough
Haemoptysis
Fatigue
Loss of appetite

Rare: dyspnoea, pleuritic chest pain

51
Q

What are the signs on physical examination of tuberculosis?

A
Lymphadenitis
Anorexia 
Abnormal chest auscultation - crackles, bronchial breath sounds
Clubbing
Erythema Nodosum

If leads to systemic miliary TB - signs and symptoms of other organs affected eg hepatomegaly if hepatitis caused

52
Q

What are the appropriate investigations for TB?

A

PPD intradermal skin test/tuberculin/mantoux test:
Tuberculin injected between layers of dermis
Immune reaction with 48-72 hours if previously infected (large area of induration)

Interferon gamma release assay - looks for evidence in blood of mycobacterium

CXR - fibronodular opacities in upper lobes with or without cavitation. Ghon complex (ghon focus and caseating hilar lymph node), calcification, hilar lymphadenopathy

Sputum sample/bronchoalveolar lavage - staining, culture, PCR - positive for acid-fast bacilli

FBC - high WBC, low Hb

Nucleic Acid Amplification Test (NAAT) - positive for mycobacterium tuberculosis

Sputum acid-fast bacilli smear: +ve for acid-fast bacilli

53
Q

Define bronchiectasis

A

An obstructive lung disorder characterised by chronic dilation of the bronchi and bronchioles with mucuous plugging of the airways, due to recurrent infections.

54
Q

Summarise the aetiology of bronchiectasis

A

Chronic lung inflammation leads to fibrosis and permanent dilation of the bronchi. This leads to pooling of mucus, which predisposes to further cycles of infection, damage and fibrosis of bronchial walls resulting in progressive bronchial damage

Primary ciliary dyskinesia - unable to clear mucous leading to recurrent pneumonia
Cystic fibrosis - thick mucuous leading to recurrent pneumonia
Tumour in or outside airway causing airway obstruction
Foreign object lodged in the airway causing obstruction preventing mucociliary clearance
Idiopathic (50%)
Post infectious: pneumonia, Pertussis, TB
Immunodeficiency: HIV
α1-antitrypsin deficiency
Connective tissue disorders: Rheumatoid arthritis, Sjogren’s Syndrome
IBD: UC or Crohns

55
Q

Summarise the epidemiology of bronchiectasis

A

Most often arises in childhood

Incidence decreases with the use of antibiotics

56
Q

What are the presenting symptoms of bronchiectasis?

A
Chronic cough
Cough productive of thick cloudy/opaque sputum or yellow/green if infection
Cough and sputum production worsened by lying flat or on side
Recurrent infections
Wheeze
Shortness of breath
Fever
Fatigue
Weight loss
Haemoptysis
Pleuritic chest pain
57
Q

What are the signs on physical examination of bronchiectasis?

A

Fever
Clubbing
Wheeze
Use of accessory muscles
Tachypnoea
Coarse crepitations – usually at lung bases and shifts on coughing
Inspiratory squeaks and crackles (quite characteristic of bronchiectasis if present)

58
Q

What are the appropriate investigations for bronchiectasis?

A
Pulmonary function tests - show obstructive lung pattern:
Decreased lung capacity
Decreased ability to force air out
Reduced FEV1
Increased RV/TLC

CT - shows dilated bronchi and bronchioles with thickened walls - DIAGNOSTIC

CXR: dilated bronchi, fibrosis, atelectasis, pneumonic consolidations (may be NORMAL)

Genetic testing for PCD, CF
Serum alpha 1 antitrypsin

Sputum sample, culture and sensitivity during exacerbation - PSEUDOMONAS AERUGINOSA is most often causative, haemophilus influenzae, staph aureus, streptococcus pneumoniae, Klebsiella, mycobacteria

59
Q

Explain the management of bronchiectasis

A

Flu vaccination, maintain hydration

Acute exacerbations:
TWO IV ANTIBIOTICS that cover Pseudomonas aeruginosa - amoxicillin or clarithromycin

Prophylaxis:
Antibiotics in patients with frequent exacerbations (> 3 times a year) - Long-term macrolide azithromycin

Inhaled Corticosteroids (e.g. fluticasone): reduces inflammation and volume of sputum (does NOT affect the frequency of exacerbations or lung function)
Bronchodilators considered in patients with responsive disease i.e. salbutamol, ipratropium 

Physiotherapy - sputum and mucus clearance

Bronchial artery embolisation: if life-threatening haemoptysis due to bronchiectasis

Surgical: localised resection, lung or heart lung transplantation

60
Q

What are the possible complications of bronchiectasis?

A

Pulmonary hypertension
Right ventricular hypertrophy (leading to cor pulmonale)
Recurrent chest infections and pneumonias
Massive haemoptysis
Respiratory failure
Empyema

61
Q

Summarise the prognosis of bronchiectasis

A

Irreversible
Periods of symptom control and periods of acute exacerbations
Often associated with other respiratory problems
Most patients continue to have symptoms after 10 years

62
Q

Define pneumothorax

A

Air accumulation in the pleural space

Tension pneumothorax: air entry to the pleural space occurs but a flap of tissue prevents air exit, leading to a medical emergency

63
Q

Summarise the aetiology of pneumothorax

A

Primary spontaneous pneumothorax:
In patients with no underlying respiratory conditions and no precipitating trauma or event
Rupture of bullae
Often in tall, thin, young males after holding breath

Secondary spontaneous pneumothorax:
Develops in individuals with underlying respiratory disease eg COPD, asthma, cystic fibrosis, Marfan’s, lung cancer, emphysema

Traumatic pneumothorax:
Following puncture of parietal pleural eg rib fracture, gunshot, stab, post-medical procedure

Tension pneumothorax:
Develops from traumatic or spontaneous pneumothorax
One way valve made from tissue, preventing air exit

64
Q

Summarise the epidemiology of pneumothorax

A

Annual incidence: 9/100,000
Mainly in 20-40 year olds
4 times more common in males
More common in smokers

65
Q

What are the presenting symptoms of pneumothorax?

A

If small spontaneous pneumothorax, could be asymptomatic

Pleuritic chest pain
Dyspnoea
Sudden onset

Tension pneumothorax: laboured respiration, rapid shallow breathing

66
Q

What are the signs on physical examination of pneumothorax?

A
Tachypnoea
Tachycardia
Ipsilateral hyperexpansion of the chest
Ipsilateral reduced breath sounds
Ipsilateral hyperresonance on percussion
Ipsilateral decreased vocal fremitus
Sweating
Tension Pneumothorax: 
Severe Respiratory Distress
Tachycardia
Hypotension 
Cyanosis 
Distended Neck Veins
Tracheal Deviation to contralateral side
67
Q

What are the appropriate investigations for pneumothorax?

A

Chest X-Ray:
See outline of collapsed lung
No pulmonary vessel markings outside the collapsed lung outline
Flattening of hemidiaphragm
Deepening of costophrenic angle
Tension pneumothorax - trachea and mediastinal deviation away

Use expiratory film - makes small pneumothoraces more obvious
Fluid level seen if blood present

CT Chest: More sensitive than CXR, useful in patients with underlying respiratory disease, useful in differentiating pneumothorax from bullous emphysema

Other: Chest US, Bronchoscopy, ABG (to determine if there is hypoxaemia particularly in secondary disease)

68
Q

What is the management of pneumothorax?

A

Supplemental oxygen

Primary spontaneous pneumothorax <2cm - discharge and repeat CXR in 1-2 weeks

Primary spontaneous pneumothorax >2cm - aspiration with large bore cannula, chest drain if unsuccessful

Secondary pneumothorax <2cm - aspiration with large bore cannula

Secondary pneumothorax >2cm - chest drain

Follow up with CXR 2 hours and 2 weeks later

Needle aspiration = 2nd ICS at MCL above rib
Chest drain = 4th or 5th ICS at anterior axillary line
Stop needle aspiration if patient coughs or resistance felt

69
Q

What are the possible complications of pneumothorax?

A

Recurrent Pneumothoraxes
Bronchopleural Fistula
Re-expansion pulmonary oedema

70
Q

Summarise the prognosis of pnuemothorax

A

After one spontaneous pneumothorax at least 20% have another
Recurrent pneumothoraces more common if secondary spontaneous pneumothorax
Frequency increases with repeated pneumothoraxes

71
Q

Define mesothelioma

A

An aggressive epithelial neoplasm arising from the lining of the lung, abdomen, pericardium, or tunica vaginalis, which is highly associated with exposure to asbestos.

72
Q

Define the aetiology of mesothelioma

A

Mesothelioma is heavily associated with asbestos exposure, with a latency period of 20-40 years between exposure and development of disease.
Often construction workers - insulation, roof tiles, painting

Other possible aetiologies:
Exposure to radiotherapy
Genetic predisposition - BAP 1 mutation
Simian virus 40 (SV-40)

73
Q

Summarise the epidemiology of mesothelioma

A

More common in males
More common in elderly 60-90 years old
More common in Caucasians

74
Q

What are the presenting symptoms of mesothelioma?

A
Shortness of breath
Dry, non-productive cough
Chest pain
Haemoptysis if invades blood vessels
Constitutional symptoms: fatigue, fever, sweats, weight loss

Abdominal distension and pain if it spreads to abdomen

75
Q

What are the signs on physical examination of mesothelioma?

A

Weight loss
Diminished breath sounds
Dullness to percussion

76
Q

What are the appropriate investigations of mesothelioma?

A

CXR - may show pleural thickening, pleural effusion of pneumothorax, reduced lung volume, parenchymal changes i.e. lower zone linear interstitial fibrosis (asbestos exposure)

CT: pleural thickening and/or discrete pleural plaques, pleural and/or pericardial effusions; enlarged hilar and/or mediastinal lymph nodes; chest wall invasion and/or spread along needle tracts can occur

Pleural biopsy and staining - shows increased calretinin
Chest MRI
PET scan
Metabolic panel - usually normal
FBC - usually normal, if low Hb and platelets and elevated WCC then advanced disease

77
Q

Define asbestosis

A

Diffuse intersitial fibrosis of the lung due to exposure to asbestos, which occurs >10 years after exposure.

78
Q

Summarise the aetiology of asbestosis

A

Caused by chronic lung disease caused by inhalation of asbestos fibres

Risk factors:
Occupational exposure (asbestos miners, aircraft & auto mechanics, boiler operators, building construction workers)
Cigarette smoking

79
Q

Summarise the epidemiology of asbestosis

A

Latency period of around 20 years from first time of exposure
Patients usually present at around > 50 years old
In the UK 5,000 asbestos related deaths per year

80
Q

What are the presenting symptoms of asbestosis?

A
SOB on exertion 
Persistent dry, non-productive cough
Appetite loss
Weight loss
Chest tightness or pain
81
Q

What are the signs on physical examination of asbestosis?

A

Crackles

Clubbing

82
Q

What are the appropriate investigations of asbestosis?

A

CXR - diffuse interstitial lung fibrosis, particularly lower zone. Pleural thickening, pleural plaques

Pulmonary function tests - non specific. Restrictive picture (decrease FVC, FEV1, TLC, normal FEV1/FVC). If chronic exposure and also smoking, could be obstructive

CT - more specific

Biopsy
Bronchial lavage containing asbestos particles

83
Q

Define obstructive sleep apnoea

A

Episodes of partial or complete upper airway obstruction during sleep, leading to cessation of breathing, oxyhaemoglobin desaturations and wakening from sleep.

84
Q

Summarise the aetiology of obstructive sleep apnoea

A

Narrowing of the upper airway during sleep due to collapse of soft tissues of pharnyx due to decreased tone of pharyngeal dilators

Obesity
Oropharyngeal narrowing
Severe overbite and other maxillomandibular abnormalities
Adenoid or tonsil swelling
Allergy-induced inflammation
Macroglossia
Male
Post-menopause
Hypothyroidism
PCOS
Marfan's syndrome
Alcohol and sedative use
85
Q

Summarise the epidemiology of obstructive sleep apnoea

A

More common with increasing age
More common in men

COMMON:
5-10% of men > 35 years old
2-15% of women > 35 years old

86
Q

What are the presenting symptoms of obstructive sleep apnoea?

A
Excessive daytime tiredness
Lack of concentration
Loud snoring prior to apnoea reported by partner
Waking during the night/restless sleep
Episodes of gasping during the night
Headaches during the day (morning headaches) due to sleep deprivation
Irritability and mood changes
Dry mouth
87
Q

What are the signs on physical examination of obstructive sleep apnoea?

A
Overweight
Large neck circumference - >42cm males, >40cm females
Macroglossia
Maxomandibbular abnormalities
Enlarged tonsils 
Long or thick uvula 
Retrognathia (pulled back jaws)
Hypertension
88
Q

What are the appropriate investigations for obstructive sleep apnoea?

A
Sleep study/polysomnography:
EEG
Airflow
EMG
Pulse oximetry
Capnography
Heart rate
Respiratory effort

Bloods: TFT’s (rule out hypothyroid as sleepiness cause), ABG
Epworth sleepiness scale

89
Q

Define pneumonia

A

Infection and inflammation of the alveoli in the lungs caused by a microbe with consolidation and interstitial lung infiltrates

90
Q

Summarise the aetiology of pneumonia

A

CAP:
Streptococcus pneumoniae
Haemophilus influenza
Moraxella catarralis

HAP:
Staphylococcus aureus
Pseudomonas aeurginosa
Klebsiella

Atypical pneumonia:
Mycoplasma pneumoniae
Chlamydia psittaci
Chlamydia pneumoniae
Legionella pneumophila
91
Q

What are the risk factors of pneumonia?

A
Age >65 years old
Hospital admission
Immunocompromise
Smoking
Travel
COPD
Alcohol
92
Q

Summarise the epidemiology of pneumonia?

A

Annual incidence rate is approximately 6 cases per 1000 people in individuals aged 18–39 years

93
Q

What are the presenting symptoms of pneumonia?

A
Productive cough - purulent yellow sputum
Dyspnoea
Pleuritic chest pain
Fever
Chills
Rigors
Fatigue
Atypical:
Dry cough
Headache
Myalgia
Diarrhoea

Older patients: confusion, worsening of underlying disease

94
Q

What are the signs on physical examination of pneumonia?

A
Tachycardia
Tachypnoea
Reduced chest expansion
Reduced breath sounds
Dull percussion note
Increased vocal fremitus
Increased tactile fremitus
Cyanosis
Bronchial breath sounds
Bibasal inspiratory coarse crackles
Low oxygen saturations
95
Q

What are the appropriate investigations for pneumonia?

A

FBC - elevated WBC
CRP/ESR - elevated
Sputum culture

CXR:
Bronchopulmonary pneumonia - patchy areas throughout the lung
Lobar - consolidation localised to a zone
Atypical - reticular markings around perihilar region

96
Q

What is the management of pneumonia?

A
Acute:
Sit patient up and give O2
Fluids
CPAP if required
Surgical drainage if abscess or empyema
Antibiotics:
Usually give amoxicillin and chlarithromycin
Typicals - amoxicillin or co-amoxiclav
Atypicals - chalrithromycin
Staph - flucloxacillin and gentamycin
MRSA = vancomycin
97
Q

What are the possible complications of pneumonia?

A
Pleural effusion
Pneumatoceles
Lung abscess
Sepsis
Empyema
Necrotising pneumonia
Pneumothorax
ARDS
98
Q

What is the prognosis of pneumonia?

A

Most people with pneumonia improve after three to five days of antibiotic treatment, but a mild cough and fatigue can last longer.
Pneumonia can also be fatal.

Mortality evaluated with CURB-65 score
C - confusion <8 AMTS
U - urea >7mmol/L
R - respiratory rate >30
B - blood pressure <90/60mmHg
>65 years old
0-1 = outpatient, low risk
2 = intermediate risk, short stay
3-5 = high risk, inpatient +/- ITU